VAN ECK ASSOCIATES CORP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of NOVAVAX INC
ValueSharesWeighting
Q2 2022$5,626,000
-40.8%
109,388
-15.2%
0.02%
-25.0%
Q1 2022$9,501,000
-43.7%
129,006
+9.3%
0.02%
-48.7%
Q4 2021$16,886,000
-30.3%
118,026
+0.9%
0.04%
-36.1%
Q3 2021$24,240,000
-16.1%
116,925
-14.1%
0.06%
-10.3%
Q2 2021$28,890,000
-4.9%
136,074
-18.8%
0.07%
-18.1%
Q1 2021$30,387,000
+147.0%
167,598
+51.9%
0.08%
+130.6%
Q4 2020$12,300,000
-24.7%
110,304
-26.9%
0.04%
+38.5%
Q3 2020$16,342,000150,8300.03%
Other shareholders
NOVAVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders